Hungary’s largest drugmaker Gedeon Richter announced that the US Food and Drug Administration (FDA) has accepted for review ...

South Korea’s Samsung Biologics today confirmed that the Seoul High Court has ruled in the company's favor, granting an ...

European recommendations for new medicines and changes to drug development procedures featured among regulatory updates from October 13 to 19. The European Medicines Agency (EMA) recommended ...

A New Delhi drugmaker, India's fourth largest by its own count, that sells branded medicines and consumer health brands at ...

Today marks the launch of Global Week 2026, running from October 19-24, an online, international awareness campaign led by ...

When a medicine wins approval, the announcement usually gives readers the indication, the main trial results and a description of its potential role. Understanding why regulators accepted the evidence ...

Last week’s significant research news included Revolution Medicines presenting new data on its cancer drug Rasonque in KRAS ...

The US Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would improve the accuracy of provider ...

US genetic medicines developer Estuary Biotherapeutics today announced its launch with $103 million in total committed ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended four novel medicines and two biosimilars ...

Singapore based clinical-stage biotech Adlai Nortye Group has entered into clinical trial collaboration and supply agreements ...

US healthcare investment firm OrbiMed has raised $3 billion in commitments for two funds targeting companies across the USA, ...